116 related articles for article (PubMed ID: 38904500)
21. Aortic regurgitation is common in hypertrophic cardiomyopathy: An echocardiography and cardiovascular magnetic resonance study.
Chen Z; Cui C; Yin G; Jiang Y; Wu W; Lei J; Guo S; Zhang Z; Arlene S; Arai AE; Zhao S; Lu M
Eur J Radiol; 2020 Mar; 124():108836. PubMed ID: 32006932
[TBL] [Abstract][Full Text] [Related]
22. Impact of left ventricular outflow tract area on systolic outflow velocity in hypertrophic cardiomyopathy: a real-time three-dimensional echocardiographic study.
Qin JX; Shiota T; Lever HM; Rubin DN; Bauer F; Kim YJ; Sitges M; Greenberg NL; Drinko JK; Martin M; Agler DA; Thomas JD
J Am Coll Cardiol; 2002 Jan; 39(2):308-14. PubMed ID: 11788224
[TBL] [Abstract][Full Text] [Related]
23. 4D flow MRI left atrial kinetic energy in hypertrophic cardiomyopathy is associated with mitral regurgitation and left ventricular outflow tract obstruction.
Gupta AN; Soulat G; Avery R; Allen BD; Collins JD; Choudhury L; Bonow RO; Carr J; Markl M; Elbaz MSM
Int J Cardiovasc Imaging; 2021 Sep; 37(9):2755-2765. PubMed ID: 33523363
[TBL] [Abstract][Full Text] [Related]
24. Spatial relationship between mitral valve and ventricular septum assessed by resting echocardiography to diagnose left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Verheyen N; Batzner A; Zach D; Zirlik A; Gerull B; Frantz S; Maack C; Störk S; Seggewiss H; Morbach C
Eur Heart J Cardiovasc Imaging; 2023 May; 24(6):710-718. PubMed ID: 36841935
[TBL] [Abstract][Full Text] [Related]
25. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
Olivotto I; Maron BJ; Tomberli B; Appelbaum E; Salton C; Haas TS; Gibson CM; Nistri S; Servettini E; Chan RH; Udelson JE; Lesser JR; Cecchi F; Manning WJ; Maron MS
J Am Coll Cardiol; 2013 Jul; 62(5):449-57. PubMed ID: 23643593
[TBL] [Abstract][Full Text] [Related]
26. Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Maron MS; Rastegar H; Dolan N; Carpino P; Koethe B; Maron BJ; Rowin EJ
Am J Cardiol; 2022 Jan; 163():91-97. PubMed ID: 34785034
[TBL] [Abstract][Full Text] [Related]
27. Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.
Lu DY; Ventoulis I; Liu H; Kudchadkar SM; Greenland GV; Yalcin H; Kontari E; Goyal S; Corona-Villalobos CP; Vakrou S; Zimmerman SL; Abraham TP; Abraham MR
Am Heart J; 2020 Jan; 219():58-69. PubMed ID: 31726421
[TBL] [Abstract][Full Text] [Related]
28. Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy.
Rowin EJ; Maron MS; Wells S; Patel PP; Koethe BC; Maron BJ
J Am Heart Assoc; 2019 Nov; 8(21):e012041. PubMed ID: 31663408
[TBL] [Abstract][Full Text] [Related]
29. Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications.
Viliani D; Pozo E; Aguirre N; Cecconi A; Olivera MJ; Caballero P; Jiménez-Borreguero LJ; Alfonso F
Int J Cardiovasc Imaging; 2017 Nov; 33(11):1771-1780. PubMed ID: 28536896
[TBL] [Abstract][Full Text] [Related]
30. First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Sorajja P; Pedersen WA; Bae R; Lesser JR; Jay D; Lin D; Harris K; Maron BJ
J Am Coll Cardiol; 2016 Jun; 67(24):2811-8. PubMed ID: 27311518
[TBL] [Abstract][Full Text] [Related]
31. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
[TBL] [Abstract][Full Text] [Related]
32. Relationship between outflow obstruction and left ventricular functional impairment in hypertrophic cardiomyopathy: a Doppler echocardiographic study.
Araujo AQ; Arteaga E; Ianni BM; Fernandes F; Ramires FJ; Buck PC; Salemi VM; Nastari L; Mady C
Echocardiography; 2006 Oct; 23(9):734-40. PubMed ID: 16999691
[TBL] [Abstract][Full Text] [Related]
33. Marked respiratory-related fluctuations in left ventricular outflow tract gradients in hypertrophic obstructive cardiomyopathy: an observational study.
Jain R; Osranek M; Jan MF; Kalvin LR; Olet S; Allaqaband SQ; Jahangir A; Khandheria BK; Tajik AJ
Eur Heart J Cardiovasc Imaging; 2018 Oct; 19(10):1126-1133. PubMed ID: 28950345
[TBL] [Abstract][Full Text] [Related]
34. The frequency and functional impact of overlapping hypertension on hypertrophic cardiomyopathy: a single-center experience.
Aslam F; Haque A; Foody J; Shirani J
J Clin Hypertens (Greenwich); 2010 Apr; 12(4):240-5. PubMed ID: 20433544
[TBL] [Abstract][Full Text] [Related]
35. Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.
Meghji Z; Nguyen A; Fatima B; Geske JB; Nishimura RA; Ommen SR; Lahr BD; Dearani JA; Schaff HV
JAMA Cardiol; 2019 Mar; 4(3):237-245. PubMed ID: 30810698
[TBL] [Abstract][Full Text] [Related]
36. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
Yazaki K; Suzuki A; Shiga T; Minami Y; Arai K; Ashihara K; Shoda M; Hagiwara N
BMC Cardiovasc Disord; 2021 Feb; 21(1):106. PubMed ID: 33607967
[TBL] [Abstract][Full Text] [Related]
37. Left atrial dysfunction as marker of poor outcome in patients with hypertrophic cardiomyopathy.
Essayagh B; Resseguier N; Michel N; Casalta AC; Renard S; Donghi V; Carbone A; Piazzai C; Ambrosi P; Levy F; Martel H; Gérard H; Avierinos JF; N'Guyen K; Habib G
Arch Cardiovasc Dis; 2021 Feb; 114(2):96-104. PubMed ID: 33039326
[TBL] [Abstract][Full Text] [Related]
38. Implication of Apnea-Hypopnea Index, a Measure of Obstructive Sleep Apnea Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
Xu H; Wang J; Yuan J; Hu F; Yang W; Guo C; Luo X; Liu R; Cui J; Gao X; Chun Y; Qiao S
J Am Heart Assoc; 2020 Apr; 9(8):e015013. PubMed ID: 32297565
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in cardiac magnetic resonance features in patients with hypertrophic cardiomyopathy.
Nogales-Romo MT; Cecconi A; Olivera MJ; Caballero P; Hernández S; Jiménez-Borreguero LJ; Alfonso F
Int J Cardiovasc Imaging; 2020 Sep; 36(9):1751-1759. PubMed ID: 32405733
[TBL] [Abstract][Full Text] [Related]
40. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
